PlainRecalls
FDA Drug Low Class III Ongoing

Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.

Reported: August 27, 2025 Initiated: July 24, 2025 #D-0593-2025

Product Description

Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.

Reason for Recall

Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.

Details

Recalling Firm
Cipla USA, Inc.
Units Affected
20352 packs (1x 200 MD)
Distribution
U.S. Nationwide.
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.. Recalled by Cipla USA, Inc.. Units affected: 20352 packs (1x 200 MD).
Why was this product recalled?
Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 27, 2025. Severity: Low. Recall number: D-0593-2025.